Skip to main content

ORIGINAL RESEARCH article

Front. Med.

Sec. Dermatology

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1574413

Advancement and Independent Validation of a Deep Learning-based tool for Automated Scoring of Nail Psoriasis Severity Using the Modified Nail Psoriasis Severity Index

Provisionally accepted
Stephan Kemenes Stephan Kemenes 1Liu Chang Liu Chang 2Maja Schlereth Maja Schlereth 3Rita Noversa De Sousa Rita Noversa De Sousa 4Ioanna Minopoulou Ioanna Minopoulou 5Pauline Fenzl Pauline Fenzl 4Giulia Corte Giulia Corte 4Melek Yalcin Mutlu Melek Yalcin Mutlu 6Michael Wolfgang Höner Michael Wolfgang Höner 1Ioannis Sagonas Ioannis Sagonas 1David Simon David Simon 5Arnd Kleyer Arnd Kleyer 5Lukas Folle Lukas Folle 2Michael Sticherling Michael Sticherling 7Georg Andreas Schett Georg Andreas Schett 6Andreas K Maier Andreas K Maier 2Filippo Fagni Filippo Fagni 4*
  • 1 Department of Dermatology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany
  • 2 Pattern Recognition Lab, Department of Computer Science, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany
  • 3 Department Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany
  • 4 Department of Internal Medicine 3 – Rheumatology and Immunology,, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany
  • 5 Department of Rheumatology, Charite University Hospital, Berlin, Baden-Württemberg, Germany
  • 6 Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany
  • 7 Department of Dermatology,, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany

The final, formatted version of the article will be published soon.

    Objective: To improve and validate a convolutional neural network (CNN)-based model for the automated scoring of nail psoriasis severity using the modified Nail Psoriasis Severity Index (mNAPSI) with adequate accuracy across all severity classes and without dependency on standardized conditions.Methods: Patients with psoriasis (PsO), psoriatic arthritis (PsA), and non-psoriatic controls including healthy individuals and patients with rheumatoid arthritis were included for training, while validation utilized an independent cohort of psoriatic patients. Nail photographs were pre-processed and segmented and mNAPSI scores were annotated by five expert readers. A CNN based on Bidirectional Encoder representation from Image Transformers (BEiT) architecture and pre-trained on ImageNet-22k was fine-tuned for mNAPSI classification. Model performance was compared with human annotations by using area under the receiver operating characteristic curve (AUROC) and other metrics. A reader study was performed to assess inter-rater variability.Results: In total, 460 patients providing 4400 nail photographs were included in the training dataset.The independent validation dataset included 118 further patients who provided 929 nail photographs.The CNN demonstrated high classification performance on the training dataset, achieving mean (SD) AUROC of 86%±7% across mNAPSI classes. Performance remained robust on the independent validation dataset, with a mean AUROC of 80%±9%, despite variability in imaging conditions.Compared with human annotation, the CNN achieved a Pearson correlation of 0.94 on a patient-level, which remained consistent in the validation dataset.We developed and validated a CNN that enables the automated, objective scoring of nail psoriasis severity based on mNAPSI with high reliability and without need of image standardization. This approach has potential clinical utility for enabling a standardized time-efficient assessment of nail involvement in the psoriatic disease and possibly as a self-reporting tool.

    Keywords: Psoriasis, psoriatic arthritis, Nail disease, NAPSI, MNAPSI, artificial intelligence, machine learning, outcome measures

    Received: 10 Feb 2025; Accepted: 18 Mar 2025.

    Copyright: © 2025 Kemenes, Chang, Schlereth, Noversa De Sousa, Minopoulou, Fenzl, Corte, Yalcin Mutlu, Höner, Sagonas, Simon, Kleyer, Folle, Sticherling, Schett, Maier and Fagni. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Filippo Fagni, Department of Internal Medicine 3 – Rheumatology and Immunology,, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more